These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1386503)

  • 1. [Atrial natriuretic factor and cardiac insufficiency].
    Komajda M; Isnard R; Carayon A
    Arch Mal Coeur Vaiss; 1992 Apr; 85(4):473-7. PubMed ID: 1386503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial natriuretic factor. Current data and future perspectives].
    Michel JB; Arnal JF
    Arch Mal Coeur Vaiss; 1990 Dec; 83(14):2111-21. PubMed ID: 2178342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor in chronic heart failure.
    Northridge DB; McMurray J; Dargie HJ
    Herz; 1991 Apr; 16(2):92-101. PubMed ID: 1829707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of natriuretic peptides in clinical practice].
    Lazúrová I; Kramer HJ
    Vnitr Lek; 1994 Mar; 40(3):194-8. PubMed ID: 8184576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor: implications in congestive heart failure and hypertension.
    Burnett JC
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():41-6. PubMed ID: 2528638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial natriuretic factor as a marker of clinical severity in cardiac failure].
    Suchmanová-Lazúrová I; Rybár R; Majercák I; Valocík G; Fedorová E; Machánová Y; Tkácová R; Trejbal D
    Vnitr Lek; 1993 Oct; 39(10):1003-7. PubMed ID: 8236862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor in acute and chronic cardiac failure.
    Riegger GA; Kromer EP; Wild S; Hofbauer H; Klug ML; Kochsiek K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S161-5. PubMed ID: 2485023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular actions of atrial natriuretic factor in sheep with cardiac failure.
    Parkes DG; Coghlan JP; Cooper EA; Routley M; McDougall JG; Scoggins BA
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):905-12. PubMed ID: 7826554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial natriuretic peptide in cardiac insufficiency].
    Riegger AJ
    Arzneimittelforschung; 1988 Mar; 38(3A):479-83. PubMed ID: 2969247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial natriuretic factor in heart insufficiency].
    Isnard R; Komajda M; Carayon A
    Presse Med; 1992 Sep; 21(29):1381-5. PubMed ID: 1454768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver.
    Arendt RM; Gerbes AL; Ritter D; Stangl E; Bach P; Zähringer J
    J Hypertens Suppl; 1986 Jun; 4(2):S131-5. PubMed ID: 2941536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy.
    Gutkowska J; Nemer M; Sole MJ; Drouin J; Sirois P
    J Clin Invest; 1989 May; 83(5):1500-4. PubMed ID: 2523413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
    Ma J; Peng A; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is atrial natriuretic factor a physiological regulator of sodium excretion? A review of the evidence.
    Richards AM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S39-42. PubMed ID: 1708021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic factor as a marker in congestive heart failure.
    Michel JB; Arnal JF; Corvol P
    Horm Res; 1990; 34(3-4):166-8. PubMed ID: 1966565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.